BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

EFAS Lyon 2021 - Hybrid Annual Meeting

October 21-22-23 - Combined Face to Face and Virtual Meeting

The EFAS Congress Lyon 2021 will be the first hybrid congress from the European Foot and Ankle Society. 

EFAS hopes BOFAS members and others will join them in person for 3 amazing days of congress, to meet each other and exchange ideas, but in the current climate going abroad might still be difficult. EFAS would therefore like to extend the opportunity for all to be part of the congress by going HYBRID for the first time. 

Annual Meeting 2021 - Recap

The 2021 Annual Meeting is over, but click here if you missed it!

We hope you enjoyed the 2021 Virtual Annual meeting, but if you could not make it, it's available for members free of charge! Follow the link to view the programme and recordings. 

123456789

 

BOFAS Hosted Events

Courses organised by BOFAS
 

 

BOFAS Affiliated Courses

Courses by organisations with an affiliation to BOFAS
 

Other External Events / Courses

Independant courses organised by other organisations not directly affiliated with BOFAS, but which BOFAS members may find of value.
 
Togay Koç
/ Categories: Abstracts, 2022, Podium

Clinical and radiographic outcomes of revision total ankle arthroplasty using the INBONE II prosthesis

B. Jamjoom, B. Siddiqui, H. Salem, M. Raglan, S. Dhar

Background: The literature on the outcome of revision total ankle arthroplasty (TAA) remains limited. We aim to report the clinical and radiological outcomes of revision TAA at a high-volume centre in the UK.

Methods: Retrospective review of 28 patients that underwent 29 revision TAA procedures using INBONE II prosthesis. Demographic, radiological, and patient reported outcome measures data were analysed.

Results: The mean (range) duration from primary TAA to revision was 87.5 (16-223) months.The main indication for the revision was aseptic loosening of the primary TAA (82.8%). Additional procedures were required in 75.9% of patients. At mean (range) follow-up of 40 (24-60) months, the infection, re-operation, and implant survival rates were 6.9%, 6.9% and 96.5% respectively. A significant postoperative improvement in the component alignment radiographic measures was observed. Osteolysis,subsidence, loosening and heterotopic ossification rates were comparable to other reports and did not influence the clinical outcome. A significant improvement was observed in the MOXFQ (all domains) and the EQ-5D (three domains) at 24 months postoperatively.

Conclusions: Revision TAA using INBONE II was associated with good short-term survival and improvement in the postoperative scores at 2 years. Maintenance of the postoperatively improved alignment was documented at follow up. The relatively high survival rate in this series supports the notion that revision TAA is a satisfactory option for failed primary TAA.

Print
970